Effectiveness of risk minimisation measures for valproate: a drug utilisation study based on implementation of a Risk Minimisation Programme in Europe, analysis of data from the UK

CONCLUSIONS: Results from this study indicated some improvement in physician prescribing and a potential reduction in valproate-exposed pregnancies in the UK. Given only modest improvement has been achieved, additional RMMs were implemented in 2018.PMID:34931552 | DOI:10.1080/03007995.2021.1997286

Source: Epilepsy Curr - December 21, 2021 Category: Neurology Authors: Birgit Ehlken Chihiro Nishikawa Sigal Kaplan Isabelle Dresco Denis Granados Massoud Toussi Source Type: research